Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03298698Phase 3Unknown
Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome
Focal Segmental GlomerulosclerosisIdiopathic Nephrotic SyndromeMinimal Change Disease
PrincipalinvestigatorStart date: 2018-08-22

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Radboud University Nijmegen Medical center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jack F Wetzels, MD, PhD

Radboud University Nijmegen Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalIdiopathic Nephrotic SyndromeNephrosis, Lipoid

Worked with same sponsors:

Radboud University Medical Center
Collaborated on 1 trial
Similarity Score34%

Matthias Kretzler, MD

University of Michigan

Related
3 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Radko Komers, MD, PhD

Travere Therapeutics, Inc.

Related
4 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Keenan

ValenzaBio, Inc.

Related
2 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

William A Gahl, M.D.

National Human Genome Research Institute (NHGRI)

Related
12 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Dong Ki Kim, MD, PhD

Seoul National University Hospital

Related
3 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Safak Mirioglu, MD

Department of Internal Medicine, Istanbul Faculty of Medicine

Related
4 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Halil Yazici, MD

Department of Internal Medicine, Istanbul Faculty of Medicine

Related
4 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Jeffrey B Kopp, M.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
7 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalIdiopathic Nephrotic Syndrome
Similarity Score20%

Debbie Gipson, MD

University of Michigan

Related
2 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal Segmental
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03298698Phase 3PrincipalInvestigator

Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome

Focal Segmental GlomerulosclerosisIdiopathic Nephrotic SyndromeMinimal Change Disease
Unknown

All 1 trials loaded